Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$XBiotech (XBIT.US)$ XBiotech Halts Rheumatology Program Aft...

$XBiotech (XBIT.US)$ XBiotech Halts Rheumatology Program After Phase II Rheumatoid Arthritis Study Fails To Meet Primary Endpoint Amid Data Irregularities; Future Studies On Hold Pending Further Analysis Of Findings
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
751 Views
Comment
Sign in to post a comment